TITLE

Improving anticoagulant use for prevention of venous thromboembolism

PUB. DATE
May 2010
SOURCE
American Journal of Health-System Pharmacy;5/15/2010 Supplement, Vol. 67, pS31
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents a lesson plan for continuing education, which teaches concepts on the use of anticoagulant to prevent venous thromboembolism.
ACCESSION #
56097241

 

Related Articles

  • Improving anticoagulant use for prevention of venous thromboembolism. Haines, Stuart T. // American Journal of Health-System Pharmacy;5/15/2010 Supplement, Vol. 67, pS2 

    The article discusses various reports published within the issue, including one on the prevention of venous thromboembolism (VTE) as well as the strategies to improve the use of anticoagulant to patients with VTE, one on the use of drug therapies for VTE prophylaxis, and one on the clinical and...

  • Emerging anticoagulants for venous thromboembolism prevention. Trujillo, Toby C. // American Journal of Health-System Pharmacy;5/15/2010 Supplement, Vol. 67, pS17 

    Purpose. To discuss the advantages and disadvantages of currently available anticoagulants, describe the characteristics of the ideal anticoagulant, and compare and contrast the mechanisms of action, pharmacokinetics, administration, efficacy, safety, and potential for drug interactions of...

  • Clinical and management challenges in preventing venous thromboembolism in health systems: A case-based panel discussion. Haines, Stuart T.; Dager, William E.; Trujillo, Toby C. // American Journal of Health-System Pharmacy;5/15/2010 Supplement, Vol. 67, pS26 

    Purpose. To illustrate clinical and management issues in the prevention of venous thromboembolism (VTE) in health systems. Summary. Lack of evidence to guide the choice among available anticoagulants and the dosing, timing of initiation, and duration of therapy for VTE prevention in certain...

  • Aspirin and venous thromboembolism.  // OB/GYN Clinical Alert;Jul2012, Vol. 29 Issue 3, p2 

    The article offers information regarding the use of aspirin which can be protective for patients who had venous thromboembolism in preventing it to reoccur after oral anticoagulant therapy.

  • Working Toward a System-wide Venous Thromboembolism Prophylaxis Strategy: Experience From a Multisite Health Region. Semchuk, William; Kolodziejak, Lynette; Bubbar, Carolyn; Poulin, Susan // Hospital Pharmacy;Aug2011, Vol. 46 Issue 8, p574 

    Background: Venous thromboembolism (VTE), comprised of both deep vein thrombosis (DVT) and pulmonary embolism (PE), is a common complication for hospitalized patients. Clear guidance is available to practitioners in regard to risk factors for the development of VTE as well as strategies to...

  • Therapeutic Index of Anticoagulants for Prevention of Venous Thromboembolism Following Orthopedic Surgery: A Dose-Response Meta-Analysis. Mandema, J W; Boyd, R A; DiCarlo, L A // Clinical Pharmacology & Therapeutics;Dec2011, Vol. 90 Issue 6, p820 

    Information on the comparative effectiveness of drugs is crucial for drug development decisions, in addition to being needed by regulators, prescribers, and payers. We have carried out a dose-response meta-analysis of three end points each for efficacy and bleeding for various anticoagulants...

  • Prophylactic Anticoagulant Therapy in the Orthopedic Patient. Neu Jr., Leo T.; Waterfield, Jim R.; Ash, Charles J. // Annals of Internal Medicine;Mar65, Vol. 62 Issue 3, p463 

    Focuses on a study of orthopedic patients who suffered trauma of the pelvis and lower extremities, to determine the value of routine prophylactic warfarin sodium anticoagulation in the prevention of thromboembolic phenomena. Significance of the variation between anticoagulated patients from the...

  • Heparin prophylaxis has no benefit in medical patients. Snee, Michael // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;8/4/2012, Vol. 345 Issue 7868, p29 

    The article discusses about the heparin prophylaxis for venous thromboembolism (VTE). The study found that deep vein thrombosis (DVT) in medical patients cannot to prevented and also found there is no benefit for heparin prophylaxis. The counselling given to the medical patients are highlighted.

  • Aspirin given for up to 2 years after initial anticoagulant treatment reduces the risk of venous thromboembolism recurrence without increasing risk of major bleeding. Watson, Henry G. // Evidence Based Nursing;Jul2013, Vol. 16 Issue 3, p92 

    The article discusses a study on the reduction of the risk of venous thromboembolism recurrence without increasing risk of major bleeding after stopping the intake of salicylate drug aspirin for 2 years after initial anticoagulant treatment. It states that a randomised controlled study compared...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics